In a study of 107 NSCLC cases reported by Salido et al. [74], only three (3%) cases exhibited ALK rearrangement, but 11 (10%) and 68 (63%) cases exhibited ALK amplification and copy number gains, respectively. This evidence concerns the gene ALK and non-small cell lung carcinoma.